Deep brain stimulation. Emerging indications

Progress in Brain Research

Volumn 194, Issue , 2011, Pages 83-95

  Tierney, Travis S ^a   Sankar, Tejas ^a   Lozano, Andres M ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Alzheimer's disease; Deep brain stimulation; Depression; Parkinson's disease; Pedunculopontine nucleus

Indexed keywords

ALZHEIMER DISEASE; BOOK; BRAIN DEPTH STIMULATION; COGNITION; DEPRESSION; HUMAN; MOOD; MOTOR ACTIVITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 80051860137     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53815-4.00015-7     Document Type: Chapter

References (61)

1. Aarsland D., Marsh L., Schrag A. Neuropsychiatric symptoms in Parkinson's disease. Movement Disorders 2009, 24:2175-2186.
2. Agency for Health Care Policy and Research Depression in primary care: Volume 2. Treatment of major depression 1993, Department of Health and Human Services, Public Health Service, Rockville, USA.
3. Aravanis A.M., Wang L.P., Zhang F., Meltzer L.A., Mogri M.Z., Schneider M.B., et al. An optical neural interface: In vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology. Journal of Neural Engineering 2007, 4:S143-S156.
4. Benabid A.L., Chabardes S., Seigneuret E. Deep-brain stimulation in Parkinson's disease: Long-term efficacy and safety-What happened this year?. Current Opinion in Neurology 2005, 18:623-630.
5. Blahak C., Wohrle J.C., Capelle H.H., Bazner H., Grips E., Weigel R., et al. Tremor reduction by subthalamic nucleus stimulation and medication in advanced Parkinson's disease. Journal of Neurology 2007, 254:169-178.
6. Botzel K., Kraft E. Strategies for treatment of gait and posture associated deficits in movement disorders: The impact of deep brain stimulation. Restorative Neurology and Neuroscience 2010, 28:115-122.
7. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nature Neuroscience 2005, 8:1263-1268.
8. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H.M. Forecasting the global burden of Alzheimer's disease. Alzheimer's & Dementia 2007, 3:186-191.
9. Castelli L., Rizzi L., Zibetti M., Angrisano S., Lanotte M., Lopiano L. Neuropsychological changes 1-year after subthalamic DBS in PD patients: A prospective controlled study. Parkinsonism & Related Disorders 2010, 16:115-118.
10. Dafotakis M., Fink G.R., Allert N., Nowak D.A. The impact of subthalamic deep brain stimulation on bradykinesia of proximal and distal upper limb muscles in Parkinson's disease. Journal of Neurology 2008, 255:429-437.
11. Deuschl G., Schade-Brittinger C., Krack P., Volkmann J., Schafer H., Botzel K., et al. A randomized trial of deep-brain stimulation for Parkinson's disease. The New England Journal of Medicine 2006, 355:896-908.
12. Diamond A., Shahed J., Jankovic J. The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor. Journal of the Neurological Sciences 2007, 260:199-203.
13. Dougherty D.D., Weiss A.P., Cosgrove G.R., Alpert N.M., Cassem E.H., Nierenberg A.A., et al. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. Journal of Neurosurgery 2003, 99:1010-1017.
14. Fava M. Diagnosis and definition of treatment-resistant depression. Biological Psychiatry 2003, 53:649-659.
15. Ferraye M.U., Debu B., Fraix V., Goetz L., Ardouin C., Yelnik J., et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010, 133:205-214.
16. Garcia-Rill E., Skinner R.D. The mesencephalic locomotor region. I. Activation of a medullary projection site. Brain Research 1987, 411:1-12.
17. Garcia-Rill E., Skinner R.D. The mesencephalic locomotor region. II. Projections to reticulospinal neurons. Brain Research 1987, 411:13-20.
18. Goldapple K., Segal Z., Garson C., Lau M., Bieling P., Kennedy S., et al. Modulation of cortical-limbic pathways in major depression: Treatment-specific effects of cognitive behavior therapy. Archives of General Psychiatry 2004, 61:34-41.
19. Gradinaru V., Mogri M., Thompson K.R., Henderson J.M., Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 2009, 324:354-359.
20. Guridi J., Obeso J.A., Rodriguez-Oroz M.C., Lozano A.A., Manrique M. L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease. Neurosurgery 2008, 62:311-323. discussion 323-325.
21. Hamani C., McAndrews M.P., Cohn M., Oh M., Zumsteg D., Shapiro C.M., et al. Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Annals of Neurology 2008, 63:119-123.
22. Han X., Boyden E.S. Multiple-color optical activation, silencing, and desynchronization of neural activity, with single-spike temporal resolution. PloS One 2007, 2:e299.
23. Hariz M.I., Krack P., Alesch F., Augustinsson L.E., Bosch A., Ekberg R., et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: A 6year follow-up. Journal of Neurology, Neurosurgery, and Psychiatry 2008, 79:694-699.
24. Hausdorff J.M., Gruendlinger L., Scollins L., O'Herron S., Tarsy D. Deep brain stimulation effects on gait variability in Parkinson's disease. Movement Disorders 2009, 24:1688-1692.
25. Hely M.A., Reid W.G., Adena M.A., Halliday G.M., Morris J.G. The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20years. Movement Disorders 2008, 23:837-844.
26. Johnsen E.L., Mogensen P.H., Sunde N.A., Ostergaard K. Improved asymmetry of gait in Parkinson's disease with DBS: Gait and postural instability in Parkinson's disease treated with bilateral deep brain stimulation in the subthalamic nucleus. Movement Disorders 2009, 24:590-597.
27. Karachi C., Grabli D., Bernard F.A., Tande D., Wattiez N., Belaid H., et al. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. The Journal of Clinical Investigation 2010, 120:2745-2754.
28. Laxton A.W., Tang-Wai D.F., McAndrews M.P., Zumsteg D., Wennberg R., Keren R., et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Annals of Neurology 2011, 68:521-534.
29. Lozano A.M., Mayberg H.S., Giacobbe P., Hamani C., Craddock R.C., Kennedy S.H. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biological Psychiatry 2008, 64:461-467.
30. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., et al. Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biological Psychiatry 2000, 48:830-843.
31. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., et al. Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness. The American Journal of Psychiatry 1999, 156:675-682.
32. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
33. Mayeux R., Sano M. Treatment of Alzheimer's disease. The New England Journal of Medicine 1999, 341:1670-1679.
34. Mazzone P., Sposato S., Insola A., Dilazzaro V., Scarnati E. Stereotactic surgery of nucleus tegmenti pedunculopontine [corrected]. British Journal of Neurosurgery 2008, 22(Suppl. 1):S33-S40.
35. Moro E., Hamani C., Poon Y.Y., Al-Khairallah T., Dostrovsky J.O., Hutchison W.D., et al. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain 2010, 133:215-224.
36. Moro E., Lozano A.M., Pollak P., Agid Y., Rehncrona S., Volkmann J., et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Movement Disorders 2010, 25:578-586.
37. Nagel G., Ollig D., Fuhrmann M., Kateriya S., Musti A.M., Bamberg E., et al. Channelrhodopsin-1: A light-gated proton channel in green algae. Science 2002, 296:2395-2398.
38. Nobler M.S., Oquendo M.A., Kegeles L.S., Malone K.M., Campbell C.C., Sackeim H.A., et al. Decreased regional brain metabolism after ect. The American Journal of Psychiatry 2001, 158:305-308.
39. Okun M.S., Fernandez H.H., Wu S.S., Kirsch-Darrow L., Bowers D., Bova F., et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE trial. Annals of Neurology 2009, 65:586-595.
40. Orlovsky G.N., Severin F.V., Shik M.L. Locomotion elicited by midbrain stimulation (trans. Russian). Proceedings of the Academy of Sciences of the USSR 1966, 169:1223-1226.
41. Pahapill P.A., Lozano A.M. The pedunculopontine nucleus and Parkinson's disease. Brain 2000, 123(Pt 9):1767-1783.
42. Parsons T.D., Rogers S.A., Braaten A.J., Woods S.P., Troster A.I. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: A meta-analysis. Lancet Neurology 2006, 5:578-588.
43. Pereira E.A., Muthusamy K.A., De Pennington N., Joint C.A., Aziz T.Z. Deep brain stimulation of the pedunculopontine nucleus in Parkinson's disease. Preliminary experience at Oxford. British Journal of Neurosurgery 2008, 22(Suppl. 1):S41-S44.
44. Powell T.P.S., Guillery R.W., Cowan W.M. A quantitative study of the fornix-mammillothalamic system. Journal of Anatomy 1957, 91:419-432.
45. Rodrigues A.M., Rosas M.J., Gago M.F., Sousa C., Fonseca R., Linhares P., et al. Suicide attempts after subthalamic nucleus stimulation for Parkinson's disease. European Neurology 2010, 63:176-179.
46. Schrag A. Quality of life and depression in Parkinson's disease. Journal of the Neurological Sciences 2006, 248:151-157.
47. Seminowicz D.A., Mayberg H.S., McIntosh A.R., Goldapple K., Kennedy S., Segal Z., et al. Limbic-frontal circuitry in major depression: A path modeling metanalysis. NeuroImage 2004, 22:409-418.
48. Shapiro M.B., Vaillancourt D.E., Sturman M.M., Metman L.V., Bakay R.A., Corcos D.M. Effects of STN DBS on rigidity in Parkinson's disease. IEEE Transactions on Neural Systems and Rehabilitation Engineering 2007, 15:173-181.
49. Shik M.L., Severin F.V., Orlovsky G.N. Control of walking and running by means of electrical stimulation of the mesencephalon. Electroencephalography and Clinical Neurophysiology 1969, 26:549.
50. Stefani A., Lozano A.M., Peppe A., Stanzione P., Galati S., Tropepi D., et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007, 130:1596-1607.
51. Tabbal S.D., Ushe M., Mink J.W., Revilla F.J., Wernle A.R., Hong M., et al. Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease. Experimental Neurology 2008, 211:234-242.
52. Timmermann L., Braun M., Groiss S., Wojtecki L., Ostrowski S., Krause H., et al. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease. Movement Disorders 2008, 23:218-227.
53. Vann S.D., Tsivilis D., Denby C.E., Quamme J.R., Yonelinas A.P., Aggleton J.P., et al. Impaired recollection but spared familiarity in patients with extended hippocampal system damage revealed by 3 convergent methods. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:5442-5447.
54. Weaver F.M., Follett K., Stern M., Hur K., Harris C., Marks W.J., et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: A randomized controlled trial. The Journal of the American Medical Association 2009, 301:63-73.
55. Williams A., Gill S., Varma T., Jenkinson C., Quinn N., Mitchell R., et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): A randomised, open-label trial. Lancet Neurology 2010, 9:581-591.
56. Witt K., Daniels C., Reiff J., Krack P., Volkmann J., Pinsker M.O., et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: A randomised, multicentre study. Lancet Neurology 2008, 7:605-614.
57. World Health Organization Chapter 2: Burden of mental and behavioral disorders. The WHO report 2001: Mental health, new understanding, New Hope 2001, accessed July18, 2011. http://www.who.int/whr/2001/en/.
58. York M.K., Dulay M., Macias A., Levin H.S., Grossman R., Simpson R., et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 2008, 79:789-795.
59. Zangaglia R., Pacchetti C., Pasotti C., Mancini F., Servello D., Sinforiani E., et al. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study. Movement Disorders 2009, 24:1621-1628.
60. Zhang F., Gradinaru V., Adamantidis A.R., Durand R., Airan R.D., de Lecea L., et al. Optogenetic interrogation of neural circuits: Technology for probing mammalian brain structures. Nature Protocols 2010, 5:439-456.
61. Zhang F., Wang L.P., Brauner M., Liewald J.F., Kay K., Watzke N., et al. Multimodal fast optical interrogation of neural circuitry. Nature 2007, 446:633-639.